Future Oncology Journal Issues Research Articles in Vol. 18, No. 30
November 07, 2022
November 07, 2022
LONDON, England, Nov. 7 -- Future Oncology, a journal that says it provides a forum for a new era of cancer care, published research articles on the following topics in its Vol. 18, No. 30 edition:
Clinical Trial Protocol:
* Transcatheter arterial chemoembolization plus atezolizumab and bevacizumab for unresectable hepatocellular carcinoma: a single-arm, phase II trial
* A phase II study of TAS-117 in patients with advanced solid tumors harboring germline . . .
Clinical Trial Protocol:
* Transcatheter arterial chemoembolization plus atezolizumab and bevacizumab for unresectable hepatocellular carcinoma: a single-arm, phase II trial
* A phase II study of TAS-117 in patients with advanced solid tumors harboring germline . . .